Results 1 to 10 of about 274,823 (50)

Multi-Drug Resistance Bacterial Infections in Critically Ill Patients Admitted with COVID-19. [PDF]

Microorganisms, 2021
Pasero D, Cossu AP, Terragni P.
europepmc   +1 more source

Multiple drug resistance bacterial isolates and associated factors among urinary stone patients at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. [PDF]

BMC Urol, 2021
Kasew D, Eshetie S, Diress A, Tegegne Z, Moges F.   +4 more
europepmc   +1 more source

Characterization and in vitro Analysis of Probiotic-Derived Peptides Against Multi Drug Resistance Bacterial Infections. [PDF]

Front Microbiol, 2020
Mazumdar A, Haddad Y, Sur VP, Milosavljevic V, Bhowmick S, Michalkova H, Guran R, Vesely R, Moulick A.   +8 more
europepmc   +1 more source

Drug resistance bacterial isolates in inpatients at Cocody University Hospital, Abidjan, Côte d’Ivoire in 2014 [PDF]

Antimicrob Resist Infect Control, 2015
Adele K.
europepmc   +1 more source

Human Gut Bacteriophageome: Insights Into Drug Resistance Mechanisms in Tuberculosis. [PDF]

Interdiscip Perspect Infect Dis
Jafari E, Azizian R, Tabasi M, Banakar M, Bagheri Lankarani K.   +4 more
europepmc   +1 more source

Based on quorum sensing: reverse effect of traditional Chinese medicine on bacterial drug resistance mechanism. [PDF]

Front Cell Infect Microbiol
Qiu N, Liu W, Zhang X.
europepmc   +1 more source

Advances in drug resistance and resistance mechanisms of four colorectal cancer-associated gut microbiota. [PDF]

PeerJ
Gan Y, Yang H, Wang M, Li J.
europepmc   +1 more source

Bioinspired Nanoplatforms: Polydopamine and Exosomes for Targeted Antimicrobial Therapy. [PDF]

Polymers (Basel)
Muttiah B, Hanafiah A.
europepmc   +1 more source

Bacterial genome-wide association studies: exploring the genetic variation underlying bacterial phenotypes. [PDF]

Appl Environ Microbiol
Yang Q, Wang X, Han M, Sheng H, Sun Y, Su L, Lu W, Li M, Wang S, Chen J, Cui S, Yang B-W.   +11 more
europepmc   +1 more source

Current economic and regulatory challenges in developing antibiotics for Gram-negative bacteria. [PDF]

NPJ Antimicrob Resist
Gargate N, Laws M, Rahman KM.
europepmc   +1 more source